206 related articles for article (PubMed ID: 23524089)
1. Effects of prototypic calcium channel blockers in methadone-maintained humans responding under a naloxone discrimination procedure.
Oliveto A; Mancino M; Sanders N; Cargile C; Benjamin Guise J; Bickel W; Brooks Gentry W
Eur J Pharmacol; 2013 Sep; 715(1-3):424-35. PubMed ID: 23524089
[TBL] [Abstract][Full Text] [Related]
2. Isradipine and dextromethorphan in methadone-maintained humans under a naloxone discrimination procedure.
Oliveto A; Poling J; Kosten TR; Gonsai K
Eur J Pharmacol; 2004 May; 491(2-3):157-68. PubMed ID: 15140632
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of L-type calcium channel blockers and stimulants on naloxone-precipitated withdrawal in mice acutely dependent on morphine.
Barrios M; Baeyens JM
Psychopharmacology (Berl); 1991; 104(3):397-403. PubMed ID: 1718013
[TBL] [Abstract][Full Text] [Related]
4. Participation of L-type calcium channels in ethanol-induced behavioral stimulation and motor incoordination: effects of diltiazem and verapamil.
Baliño P; Pastor R; Aragon CM
Behav Brain Res; 2010 Jun; 209(2):196-204. PubMed ID: 20122967
[TBL] [Abstract][Full Text] [Related]
5. Diltiazem and verapamil lower blood pressure in the unanaesthetized rat through CNS mechanisms involving endogenous opioids.
Rabkin SW
Clin Exp Pharmacol Physiol; 1991 Jun; 18(6):431-8. PubMed ID: 1914246
[TBL] [Abstract][Full Text] [Related]
6. The influence of three L-type calcium channel blockers on morphine effects in healthy volunteers.
Hasegawa AE; Zacny JP
Anesth Analg; 1997 Sep; 85(3):633-8. PubMed ID: 9296421
[TBL] [Abstract][Full Text] [Related]
7. Antinociceptive effects of intrathecal L-type calcium channel blockers on visceral and somatic stimuli in the rat.
Hara K; Saito Y; Kirihara Y; Sakura S; Kosaka Y
Anesth Analg; 1998 Aug; 87(2):382-7. PubMed ID: 9706935
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of calcium channel blockers and stimulants on morphine withdrawal in vitro.
Barrios M; Baeyens JM
Eur J Pharmacol; 1988 Jul; 152(1-2):175-8. PubMed ID: 2463173
[TBL] [Abstract][Full Text] [Related]
9. Effects of diltiazem, a Ca2+ channel blocker, on naloxone-precipitated changes in dopamine and its metabolites in the brains of opioid-dependent rats.
Tokuyama S; Ho IK
Psychopharmacology (Berl); 1996 May; 125(2):135-40. PubMed ID: 8783387
[TBL] [Abstract][Full Text] [Related]
10. Role of pharmacokinetic effects in the potentiation of morphine analgesia by L-type calcium channel blockers in mice.
Shimizu N; Kishioka S; Maeda T; Fukazawa Y; Yamamoto C; Ozaki M; Yamamoto H
J Pharmacol Sci; 2004 Mar; 94(3):240-5. PubMed ID: 15037808
[TBL] [Abstract][Full Text] [Related]
11. Hydromorphone-naloxone combinations in opioid-dependent humans under a naloxone novel-response discrimination procedure.
Oliveto AH; Rosen MI; Kosten TA; Hameedi FA; Woods SW; Kosten TR
Exp Clin Psychopharmacol; 1998 May; 6(2):169-78. PubMed ID: 9608349
[TBL] [Abstract][Full Text] [Related]
12. Butorphanol and nalbuphine in opioid-dependent humans under a naloxone discrimination procedure.
Oliveto A; Sevarino K; McCance-Katz E; Feingold A
Pharmacol Biochem Behav; 2002; 71(1-2):85-96. PubMed ID: 11812511
[TBL] [Abstract][Full Text] [Related]
13. Competitive and cooperative effects of Bay K8644 on the L-type calcium channel current inhibition by calcium channel antagonists.
Zahradníková A; Minarovic I; Zahradník I
J Pharmacol Exp Ther; 2007 Aug; 322(2):638-45. PubMed ID: 17475903
[TBL] [Abstract][Full Text] [Related]
14. Effects of three different L-type Ca2+ entry blockers on airway constriction induced by muscarinic receptor stimulation.
Hirota K; Hashiba E; Yoshioka H; Kabara S; Matsuki A
Br J Anaesth; 2003 May; 90(5):671-5. PubMed ID: 12697597
[TBL] [Abstract][Full Text] [Related]
15. Effects of three calcium channel antagonists (amlodipine, diltiazem and verapamil) on the protective action of lamotrigine in the mouse maximal electroshock-induced seizure model.
Luszczki JJ; Trojnar MK; Trojnar MP; Kimber-Trojnar Z; Szostakiewicz B; Zadrozniak A; Borowicz KK; Czuczwar SJ
Pharmacol Rep; 2007; 59(6):672-82. PubMed ID: 18195456
[TBL] [Abstract][Full Text] [Related]
16. Effects of diltiazem or verapamil on calcium uptake and release from chicken skeletal muscle sarcoplasmic reticulum.
Paydar MJ; Pousti A; Farsam H; Amanlou M; Mehr SE; Dehpour AR
Can J Physiol Pharmacol; 2005 Nov; 83(11):967-75. PubMed ID: 16391705
[TBL] [Abstract][Full Text] [Related]
17. Combination therapy with calcium-channel blockers and beta blockers for chronic stable angina pectoris.
Leon MB; Rosing DR; Bonow RO; Epstein SE
Am J Cardiol; 1985 Jan; 55(3):69B-80B. PubMed ID: 2857518
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of diltiazem, an L-type Ca2+ channel blocker, on naloxone-increased glutamate levels in the locus coeruleus of opioid-dependent rats.
Tokuyama S; Ho IK
Brain Res; 1996 May; 722(1-2):212-6. PubMed ID: 8813371
[TBL] [Abstract][Full Text] [Related]
19. Calcium channel blockers for heart rate control in atrial fibrillation complicated by congestive heart failure.
Heywood JT
Can J Cardiol; 1995 Oct; 11(9):823-6. PubMed ID: 7585281
[TBL] [Abstract][Full Text] [Related]
20. Diltiazem inhibits naloxone-precipitated and spontaneous morphine withdrawal in rats.
Kishioka S; Inoue N; Nishida S; Fukunaga Y; Yamamoto H
Eur J Pharmacol; 1996 Nov; 316(1):7-14. PubMed ID: 8982643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
